Angie DeRosa

Contemporary OB/GYN® Deputy Medical Editor Jon I. Einarsson, MD, PhD, MPH, hosts a panel discussion with fellow minimally invasive gynecologic surgeons (MIGS) on the novel technology of vaginal natural orifice transluminal endoscopic surgery (vNOTES).

In this interview with Contemporary OB/GYN Senior Editor Angie DeRosa, Sergio Rimola, MD, discusses the Vaccinate4All campaign of the National Hispanic Medical Association (NHMA) and how ob-gyns can approach discussions with their LatinX patients.

Michael Krychman, MD discusses his perspective as a physician during the second wave of COVID-19, and shares some insight into ways other health care professionals can cope.

The North American Society for Pediatric and Adolescent Gynecology (NASPAG) is the latest professional medical association to come out against Texas Senate Bill 8 (SB 8), also known at the Texas Heartbeat Act.

Contemporary OB/GYN® Editor in Chief Catherine Y. Spong, MD, has been appointed Chair of the Department of Obstetrics and Gynecology at UT Southwestern Medical Center in Dallas, Texas, as of September 1. Spong will hold the Paul C. McDonald Distinguished Chair in Obstetrics and Gynecology, according to a press release.

The use of “pregnant woman” or “pregnant person” and their respective plurals is being debated within many levels of the medical world, including major journals, societies, and associations. When it comes to pregnancy, what noun should prevail, or should any?

Contemporary OB/GYN Senior Editor Angie DeRosa gets insight on the current state of COVID-19 from Christina Han, MD, division director of maternal-fetal medicine at the University of California, Los Angeles, and member of its COVID-19 task force. Han is an active member of the Society for Maternal-Fetal Medicine and discusses the issues on behalf of SMFM.

We hear from Christine Isaacs, MD about the new ASCCP guidelines and what they mean for ob/gyns.

Scott Kober hosts this podcast in which he interviews Lisa Satterfield, senior director of health economics and practice management at the American College of Obstetricians and Gynecologists (ACOG). They discuss the tools and resources available to practicing ob-gyns that are focused specifically on payer and reimbursement issues.

Significant updates occurred in women’s health issues while the world was in survival mode.

Join Senior Editor Angie DeRosa as Sarah J. Kilpatrick, MD, PhD; and Christian M. Pettker, MD debate noun use.

Senior editor Angie DeRosa interviewed Sateria Venable, Founder & CEO of the Fibroid Foundation, and Ayman Al-Hendy, MD, a professor of ob/gyn at the University of Chicago Medical Center, about patient-physician collaboration when it comes to addressing uterine fibroids.

In this video, Angie DeRosa, senior editor of Contemporary OB/GYN®, interviews Michael Krychman, MD, a gynecologist who specializes in sexual health and survivorship medicine.

Two leading experts provided ACOG ACSM attendees with a high-level overview on clinically valuable updates that may have been pushed to the backburner as COVID-19-related medical care dominated 2020.

If the oath “First, do no harm” is to be carried out by medical practitioners, one area in which this can truly be practiced involves the care of transmasculine or nonbinary patients who want to become pregnant or are already pregnant, according to a session from the 2021 American College of Obstetricians and Gynecologists (ACOG) Clinical and Scientific Meeting.

“When you leave populations behind from the data, you disadvantage the population that bears the brunt of the disease,” said Melissa Simon, MD, MPH, during her presentation on recommendations to improve women's health at this year's ACOG meeting.

A session held virtually at the American College of Obstetrics and Gynecology’s (ACOG) Annual Clinical and Scientific Meeting, which started on April 30, focused on the new ASCCP guidelines and highlighted the importance of identifying risk for management of abnormal screenings.

Diversity, equity, and inclusion (DEI) was a key theme that helped to kick off the annual meeting, which was held virtually. During the Hale Lecture: Diversity and Equity in Obstetrics and Gynecology – The Patient and the Provider – Care Delivery to Employment, several ob/gyns provided their own perspectives, including sharing data on diversity in the specialty now and its implications for the future pipeline.

A team of investigators has found that women with Down Syndrome received gynecologic care at lower-than-recommended rates and at substantially lower rates than other forms of health care. The investigators have called for efforts to improve gynecologic care for this vulnerable population.

Since pregnant and lactating women were excluded in the initial trials for coronavirus disease 2019 (COVID-19) vaccines, a team of researchers now has released study results that show the Moderna and Pfizer vaccines are indeed safe and effective for this population. It is the first data to substantiate the use of mRNA vaccines in pregnancy.

When it comes to willingness to switch contraception method, a team of researchers has looked into whether method type, satisfaction with use, and confidence in correct use were independently associated with switching intentions.

The mechanism of action (MOA) of emergency contraceptive pills (ECPs) is frequently mischaracterized among the general public, according to authors of a recent study published in the journal Contraception.

The World Health Organization (WHO) had previously issued guidance recommending that pregnant women should not receive the Moderna Inc. vaccine unless the individual is at high risk of exposure or having a severe case.

Introducing Contemporary OB/GYN®'s Editor-in-Chief, Catherine Y. Spong, MD.

This article is on based on information presented at the Society for Maternal-Fetal Medicine’s 2021 Virtual Annual Meeting, which is being held from Jan. 25 to Jan. 30.

The World Health Organization (WHO) had previously issued guidance recommending that pregnant women should not receive the Moderna Inc. vaccine unless the individual is at high risk of exposure or having a severe case.

This article is on based on information presented at the Society for Maternal-Fetal Medicine’s 2021 Virtual Annual Meeting, which is being held Jan. 25 to Jan. 30.

Loïc Sentilhes, MD, PHD, presented data on tranexamic acid (TXA) for the prevention of postpartum hemorrhage after cesarean delivery: the TRAAP2 trial, on Wednesday at SMFM's 2021 Virtual Annual Meeting.

The Society for Maternal-Fetal Medicine (SMFM) is encouraging all its members to weave advocacy for maternal health and lives into their everyday work, even with the smallest steps, during its 41st Annual Pregnancy Meeting, being held virtually this week.

Three experts in maternal-fetal medicine hosted the Womxn’s Health Collaborative Symposium: Crucial conversations for careers in MFM during the Society for Maternal Fetal Medicine’s (SMFM) 41st Annual Pregnancy Meeting on Monday.